CD8A and melanoma: Adoptively transferred CD8+ T cells specific for melanoma antigens accumulate in tumor-draining lymph nodes at early time points after vaccination with peptide-pulsed DCs and IL-2 immunotherapy, and subsequently in the BM and primary tumor site [75].